Synthetic peptide corresponding to the C terminal region of human TRC8.
Sequence
C-HTGAAAEEFNDDT
Host
Goat
Clonality
Polyclonal
Isotype
IgG
Conjugate
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration
500 µg/ml
Molecular Weight
75 kDa
Predicted MW
76.0kDa
Product Form
Liquid
Formulation
Supplied in Tris Buffered Saline, pH 7.3, with 0.5% BSA and 0.02% Sodium Azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Synonyms
E3 ubiquitin-protein ligase RNF139, RING finger protein 139, RING-type E3 ubiquitin transferase RNF139, Translocation in renal carcinoma on chromosome 8 protein
TRC8 expression in Human Skeletal Muscle lysate analyzed by western blot. Cells were lysed in RIPA buffer and 35µg protein was run per lane. Primary antibody incubation was performed for 1 hour with Anti-TRC8 Antibody (A83915) at 1µg/ml and detected by chemiluminescence.
TRC8 expression in Human Placenta analyzed by immunohistochemistry. Tissue was paraffin-embedded, and antigen retrieval was achieved by steaming in citrate buffer, pH 6. Staining was performed with Anti-TRC8 Antibody (A83915) at 3.8µg/ml and revealed with alkaline phosphatase (AP).
Publishing research using Anti-TRC8 Antibody (A83915)? Please let us know so that we can list the citation on this page.
Alternative products to Anti-TRC8 Antibody (A83915)
